Smoking associated with major urologic cancer surgical complications

the ONA take:

According to a study presented at the 2015 annual meeting of the American Urological Association in New Orleans, Louisiana, researchers have found that smokers and previous smokers are more likely to experience complications during and after major urologic cancer surgery and that quitting smoking for even just 1 year significantly improves surgical outcomes.

For the study, researchers identified 9,014 patients who underwent surgery for bladder, kidney, or prostate cancer from the American College of Surgeons National Surgical Quality Improvement Program database and identified.

Results showed current smokers had an increased risk for pulmonary and kidney complications and longer duration of hospitalization after prostate cancer surgery. In addition, patients with bladder cancer who currently smoked had an increased risk for requiring further surgery and former smokers had an increased risk for readmission.

Patients with prostate cancer who had not smoked for at least 1 year prior to surgery had a similar risk for surgical complications as non-smokers and had a significantly lower risk than current smokers.

The findings suggest that health care providers should motivate patients to quit smoking prior to undergoing major surgery in order to reduce the risk for complications.

Smoking associated with major urologic cancer surgical complications
Smokers and previous smokers are more likely to experience complications during and after major urologic cancer surgery.
Patients who smoke, as well as those who once had the habit, are more likely to develop complications during and after major urologic cancer surgery, according to a new study that included researchers at Henry Ford Health System.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs